SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-027581
Filing Date
2024-02-26
Accepted
2024-02-26 17:02:36
Documents
1
Period of Report
2024-02-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm247055-12_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm247055-12_4seq1.xml 4 12123
  Complete submission text file 0001104659-24-027581.txt   13735
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 3018382500
Rubin Jonathan (Reporting) CIK: 0001836067 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 24679991